Loading company…
Rejuveron develops therapies for diseases associated with aging.
Rejuveron is a clinical-stage biotechnology company developing therapies for diseases of aging. Founded in 2019 and based in Switzerland, it was co-founded by Christian Angermayer, Matthias Steger, Prof. Manuel Serrano, and Timothy Cash. In September 2023, it raised venture debt as part of a larger USD 75 million Series B and debt funding round. The company operates laboratory facilities in Schlieren Bio-Technopark.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in